The EU Medicines Agency on Thursday published the findings of a study concluding that there is no link between the AstraZeneca vaccine and an increased risk of blood clots in vaccine recipients, that the AstraZeneca vaccine is safe and effective and that the benefits of fighting the outbreak outweigh the risks of adverse reactions, and that the EU still recommends the AstraZeneca vaccine. UK regulators say they have not found a direct link between the AstraZeneca vaccine and blood clots. France, Germany Spain Italy and other countries to reintroduce AstraZeneca vaccine.
Following the release of the EU Medicines Agency’s findings, several countries, including France, Germany and Spain, said they would reintroduce the AstraZeneca vaccine. The news follows the suspension of the vaccine in more than a dozen European countries following news of blood clots following AstraZeneca vaccination.
In an investigation into 30 rare blood clot cases, the FDA could not definitively rule out a link between the blood clot events and the vaccine, said Cook, executive director of the EU Medicines Agency. In a briefing, she said the review clearly concluded that the vaccine’s “benefits outweigh the possible risks in protecting people from the risk of death or hospitalization associated with the new coronavirus.
Cooke noted that the EU Medicines Agency will update its guidelines to include a description of potential risks in patient manuals and information for healthcare professionals. The AstraZeneca vaccine “is a safe and effective vaccine,” she said.
Separately, the U.K. Medicines and Healthcare Products Regulatory Agency said Thursday that it did not find a direct link between the AstraZeneca vaccine and blood clots. The agency said there is no evidence that vaccination is more likely to lead to blood clots than non-vaccination. Britain ordered more than 100 million doses of the AstraZeneca vaccine.
Also according to Reuters news agency, the World health Organization will release the results of the AstraZeneca vaccine survey on Friday.
The WHO Vaccine Safety Panel will release its findings on Friday regarding vaccination with the AstraZeneca New Crown vaccine, a WHO spokesman said. The organization said the WHO Global Advisory Committee on Vaccine Safety examined the data on Tuesday and reviewed reports of people developing rare clotting disorders after vaccination.
Recent Comments